What Is Chromophobe Renal Cell Carcinoma?

Chromophobe renal cell carcinoma is a rare type of kidney cancer that accounts for about 5 percent of all renal cell carcinomas. It develops from the cells that line the collecting ducts of the kidney, which are responsible for concentrating urine and maintaining the body’s salt and water balance.

The term “chromophobe” comes from how the cancer cells look under a microscope. These cells appear pale and have distinctive borders, and they react differently to special stains used in pathology. Because of these unique features, doctors can distinguish chromophobe renal cell carcinoma from other kidney cancers such as clear cell or papillary renal cell carcinoma.

Although chromophobe RCC is less common, it generally has a better prognosis than most other kidney cancer types. It tends to grow slowly and is less likely to spread beyond the kidney. Many patients are diagnosed at an early stage, often when a scan is performed for another reason. When detected early, surgery alone is often curative.

The exact cause of chromophobe RCC is not fully understood, but certain genetic changes have been linked to its development. Some cases occur as part of a rare inherited condition known as Birt–Hogg–Dubé syndrome, which causes benign skin growths and increases the risk of kidney tumors. However, most cases arise sporadically, meaning they occur by chance and are not inherited.

Chromophobe RCC usually affects adults between 50 and 70 years of age and is slightly more common in women. Risk factors such as smoking, obesity, and high blood pressure may also contribute, similar to other types of kidney cancer.

Symptoms are often absent in the early stages. When they occur, they may include blood in the urine, pain or pressure in the side or lower back, or a lump in the abdomen. Some patients may also experience fatigue or unexplained weight loss, although these signs are not specific to this cancer.

Diagnosis typically involves imaging tests such as ultrasound, CT scans, or MRI to locate and evaluate the tumor. A biopsy may be performed to confirm the diagnosis and identify chromophobe features under the microscope.

Treatment usually involves surgery, either by partial nephrectomy to remove the tumor while preserving kidney tissue or radical nephrectomy to remove the entire kidney. Because chromophobe RCC is less likely to metastasize, most patients recover well and have an excellent long-term outlook.

Looking for more questions?

Visit our Kidney Cancer Questions page for all other topics explained in plain language.